Colombia vs Netherlands: Women's share of population ages 15+ living with HIV
Colombia
18.0%
in 2024
Netherlands
18.7%
in 2024
Colombia rank
142nd
Netherlands rank
141st
Women's share of population ages 15+ living with HIV over time
- Colombia
- Netherlands
How they compare
Netherlands currently reports 18.7% against 18.0% in Colombia, a difference of 0.7%.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Colombia ahead.
Colombia ranks 142nd and Netherlands ranks 141st of 172 countries.
Across the 4 decades both report, Colombia averaged higher in 2 and Netherlands in 2.
Head to head by decade
| Decade | Colombia | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 31.1% | 18.2% | 12.9% | Colombia |
| 2000s | 19.5% | 18.4% | 1.2% | Colombia |
| 2010s | 17.8% | 18.9% | 1.0% | Netherlands |
| 2020s | 17.9% | 18.7% | 0.8% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher women's share of population ages 15+ living with hiv, Colombia or Netherlands?
- Netherlands, at 18.7% against 18.0% in Colombia as of 2024.
- What is the difference in women's share of population ages 15+ living with hiv between Colombia and Netherlands?
- 0.7%, with Netherlands ahead.
- How many years of comparable data are there for Colombia and Netherlands?
- 35 years are reported by both, from 1990 to 2024.
- How do Colombia and Netherlands rank globally for women's share of population ages 15+ living with hiv?
- Colombia ranks 142nd and Netherlands ranks 141st of 172 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Women's share of population ages 15+ living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of HIV is the percentage of people who are infected with HIV. Female rate is as a percentage of the total population ages 15+ who are living with HIV.